Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease
- 31 May 2012
- journal article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 33 (5), 1015.e7-1015.e23
- https://doi.org/10.1016/j.neurobiolaging.2010.08.003
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01-AG09029, R01-AG025259, R01-HG/AG02213, K24-AG027841, P30-AG13846)
This publication has 54 references indexed in Scilit:
- A Common Mutation in Paraoxonase-2 Results in Impaired Lactonase ActivityJournal of Biological Chemistry, 2009
- Association of paraoxonase activity and coronary blood flowAtherosclerosis, 2008
- Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular RiskJama-Journal Of The American Medical Association, 2008
- Polymorphisms in the PON gene cluster are associated with Alzheimer diseaseHuman Molecular Genetics, 2005
- Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiesJournal of Lipid Research, 2005
- Paraoxonase 1 Activity: A New Vascular Marker of Dementia?Annals of the New York Academy of Sciences, 2002
- Codon 311 (Cys → Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementiasMolecular Psychiatry, 2002
- Studies on human serum paraoxonase/arylesteraseChemico-Biological Interactions, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- New chromogenic and fluorogenic substrates for the determination of butyrylcholinesterase and arylesterase activities.Journal of Pharmacobio-Dynamics, 1980